Mortality risk factors in patients with advanced heart failure and diabetes mellitus.

Background: An accurate assessment of prognosis is an important element of the management of patients with advanced heart failure (HF) and diabetes mellitus (DM), due to the particularly unfavourable effect of concomitance of both diseases on their course and treatment efficacy.   Aims: The aim of the study was to determine the prognostic factors affecting survival in patients with HF and DM.

Methods: A retrospective analysis of clinical and laboratory data of 367 consecutive patients with advanced HF (New York Heart Association class III-IV) and DM, hospitalised in a referral centre for interventional cardiology between 2009 and 2013, was performed.

Prognostic scales in advanced heart failure.

Heart transplantation (HT) is the treatment of choice for patients with advanced heart failure (HF) who remain symptomatic despite optimal medical therapy. Due to the shortage of organs for transplantation and constantly increasing number of patients placed on waiting lists, accurate risk stratification is a crucial element of management in this population. Prognostic scales allow one to evaluate the patient prognosis, estimate the potential benefits of therapy and identify those patients most likely to benefit from advanced methods of treatment.

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure - observations from the COMMIT-HF registry.

Introduction: Diabetes mellitus (DM) and heart failure (HF) are two common diseases that often co-exist.

Aim: To explore clinical characteristics, management strategies and rates of 3-year mortality among diabetic and non-diabetic patients hospitalised in a highly specialized interventional cardiology centre.

Material And Methods: We used data from COMMIT-HF (COnteMporary Modalities In Treatment of Heart Failure), which is a single-centre, observational, prospective registry of patients with symptomatic chronic systolic HF (LVEF < 35%).

Red blood cell distribution width, relative lymphocyte count, and type 2 diabetes predict all‑cause mortality in patients with advanced heart failure.

INTRODUCTION    Early identification of patients with advanced heart failure (HF) who are at higher risk of poor outcome is an important element of patient management, both from the medical and economic standpoint. OBJECTIVES    We sought to determine the association between hematologic parameters assessed on admission and within a 3‑year follow‑up in consecutive patients with advanced HF. We also investigated the association between baseline demographic and clinical data and mortality.

One‑year survival of ambulatory patients with end‑stage heart failure: the analysis of prognostic factors.

INTRODUCTION    An increasing number of ambulatory patients are placed on orthotopic heart transplantation (OHT) waiting lists, which results in an extended waiting time and a higher mortality rate. OBJECTIVES    The aim of this study was to identify the factors associated with reduced survival during a 1‑year follow‑up in patients with end‑stage heart failure listed for an OHT. PATIENTS AND METHODS    We retrospectively analyzed the data of 221 adult patients, who were accepted for OHT in our institution over a 2‑year period between 2013 and 2014.